Cited by 3,421Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsIntraperitoneal and Appendiceal Malignancies

The DOI matches its Crossref record; 303 of the 309 references it cites were found in a registry or an index.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Open access

Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.·2016·Annals of Oncology

DOI 10.1093/annonc/mdw235

Open this paper in CoChat — free account Open PDF

Abstract

Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdw235

Cites

303 of 303 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova‐Foucher, E., Lortet‐Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,243
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Self-citation
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citation
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
Self-citation
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Self-citation
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Fong, Y., Fortner, J. G., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,722

Show all 309 references

Research works printed but not linked: 6

Stintzing, 2013, Analysis of KRAS/NRAS and BRAF mutations in FIRE-3, Eur J Cancer, 49
Venook, 2014, J Clin Oncol, 32
Collettini, 2012, Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates, Rofo, 184, 316
Lenz, 2014, Ann Oncol, 25
Garcia Alfonso, 2014, Ann Oncol, 25
Cascinu, 2015, Eur J Cancer, 51

Sorted by citations

Items 401–500 of 1,003

Roles of exosomes in metastatic colorectal cancer
Lafitte, M., Lecointre, C., & Roche, S. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00218.2019 · Cited by 45
High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study
Röhrl, K., Guren, M. G., Astrup, G. L., Småstuen, M. C., & Rustøen, T. (2019) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2019.101679 · Cited by 44
FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms
Lu, W., Fu, D., Kong, X., Huang, Z., Hwang, M., Zhu, Y., Chen, L., Jiang, K., Li, X., Wu, Y., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2786 · Cited by 44
Controlled pharmacokinetic anti-cancer drug concentration profiles lead to growth inhibition of colorectal cancer cells in a microfluidic device
Komen, J., Westerbeek, E. Y., Kolkman, R. W., Roesthuis, J., Lievens, C., van den Berg, A., & van der Meer, A. D. (2020) · Lab on a Chip · doi:10.1039/d0lc00419g · Cited by 45
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
Smeby, J., Kryeziu, K., Berg, K. C. G., Eilertsen, I. A., Eide, P. W., Johannessen, B., Guren, M. G., Nesbakken, A., Bruun, J., Lothe, R. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102923 · Cited by 45
Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay
Lyu, N., Rajendran, V. K., Diefenbach, R. J., Charles, K. A., Clarke, S. J., Engel, A. F., Sydney 1000 Colorectal Cancer Study Investigators*, Rizos, H., Molloy, M. P., & Wang, Y. (2020) · Nanotheranostics · doi:10.7150/ntno.48905 · Cited by 44
Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
Hansen, T. F., Qvortrup, C., & Pfeiffer, P. (2021) · Cancers · doi:10.3390/cancers13051031 · Cited by 43
Self-citation
Dimethylfumarate Inhibits Colorectal Carcinoma Cell Proliferation: Evidence for Cell Cycle Arrest, Apoptosis and Autophagy
Kaluzki, I., Hailemariam-Jahn, T., Doll, M., Kaufmann, R., Balermpas, P., Zöller, N., Kippenberger, S., & Meissner, M. (2019) · Cells · doi:10.3390/cells8111329 · Cited by 33
Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells
Ha, H., Chiang, J., Tsai, F., BAU, D.-T., Juan, Y., Lo, Y., Hour, M., & Yang, J. (2020) · Oncology Reports · doi:10.3892/or.2020.7882 · Cited by 45
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis
Callesen, L. B., Hamfjord, J., Boysen, A. K., Pallisgaard, N., Guren, T. K., Kure, E. H., & Spindler, K. G. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01816-4 · Cited by 43
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study
Vidal, J., Fernández‐Rodríguez, C., Casadevall, D., Alfonso, P. G., Páez, D., Guix, M., Alonso, V., Cano, M. T., Santos, C., Durán, G., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1696 · Cited by 44
Self-citation
Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
André, T., Falcone, A., Shparyk, Y. V., Moiseenko, F. V., Polo, E., Csőszi, T., Bragagnoli, A. S. C., Liposits, G. I., Chmielowska, E., Aubel, P., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00334-x · Cited by 45
Self-citation
Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
Rejali, L., Asl, R. S., Sanjabi, F., Fatemi, N., Aghdaei, H. A., Niasar, M. S., Moghadam, P. K., Mojarad, E. N., Mini, E., & Nobili, S. (2023) · Cancers · doi:10.3390/cancers15102746 · Cited by 50
The Effect of Telephone-Based Follow-Up on Adherence, Efficacy, and Toxicity of Oral Capecitabine-Based Chemotherapy
Eldeib, H. K., Abbassi, M., Hussein, M. M., Salem, S., & Sabry, N. A. (2018) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2018.0077 · Cited by 43
Sophoridine Inhibits Human Colorectal Cancer Progression via Targeting MAPKAPK2
Wang, R., Liu, H., Shao, Y., Wang, K., Yin, S., Qiu, Y., Wu, H., Liu, E., Wang, T., Gao, X., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0553 · Cited by 43
Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study
Luque-Fernández, M. Á., Gonçalves, K. D. S., Salamanca‐Fernández, E., Redondo‐Sánchez, D., Lee, S. F., Rodríguez‐Barranco, M., Carmona-Garcia, M. C., Marcos‐Gragera, R., & Sánchez, M. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.021 · Cited by 43
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
Baldin, P., den Eynde, M. V., Mlecnik, B., Bindea, G., Beniuga, G., Carrasco, J., Haicheur, N., Marliot, F., Lafontaine, L., Fredriksen, T., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.178 · Cited by 43
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)
Gebauer, F., Damanakis, A. I., Popp, F., Quaas, A., Kütting, F., Lutz, K., Held, S., Deuß, B., Goeser, T., Waldschmidt, D., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08966-3 · Cited by 43
Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles
Mori, Y., Nyuya, A., Yasui, K., Toshima, T., Kawai, T., Taniguchi, F., Kimura, K., Inada, R., Nishizaki, M., Haraga, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24735 · Cited by 42
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer
Kondo, T., Matsubara, J., Quy, P. N., Fukuyama, K., Nomura, M., Funakoshi, T., Doi, K., Sakamori, Y., Yoshioka, M., Yokoyama, A., et al. (2020) · Cancer Science · doi:10.1111/cas.14674 · Cited by 41
The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
Trullas, A., Delgado, J., Genazzani, A. A., Mueller-Berghaus, J., Migali, C., Müller-Egert, S., Zander, H., Enzmann, H. G., & Pignatti, F. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100145 · Cited by 42
Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer
Okuda, S., Shimada, Y., Tajima, Y., Yuza, K., Hirose, Y., Ichikawa, H., Nagahashi, M., Sakata, J., Ling, Y., Miura, N., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.049 · Cited by 43
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis
Ye, P., Cai, P., Xie, J., & Wei, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248775 · Cited by 42
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation
Lonardi, S., Rasola, C., Lobefaro, R., Rossini, D., Formica, V., Scartozzi, M., Frassineti, G. L., Boscolo, G., Cinieri, S., Donato, S. D., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00506 · Cited by 41
Self-citation
A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study
Shibutani, M., Maeda, K., Nagahara, H., Fukuoka, T., Matsutani, S., Kashiwagi, S., Tanaka, H., Hirakawa, K., & Ohira, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4276-y · Cited by 41
Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer
Jiang, D., Wang, X., Wang, Y., Philips, D., Meng, W., Xiong, M., Zhao, J., Sun, L., He, D., & Li, K. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02576-y · Cited by 41
Plasma clearance ofRASmutation under therapeutic pressure is a rare event in metastatic colorectal cancer
Moati, É., Blons, H., Taly, V., Garlan, F., Renault, S., Pietrasz, D., Didelot, A., Garrigou, S., Saint, A., Pernot, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32657 · Cited by 43
Self-citation
Can medical imaging identify the histopathological growth patterns of liver metastases?
Latacz, E., van Dam, P., Vanhove, C., Lladó, L., Descamps, B., Ruíz, N., Joye, I., Grünhagen, D. J., Laere, S. V., Dirix, P. R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.002 · Cited by 41
Yttrium‐90 radiation segmentectomy for hepatic metastases: A multi‐institutional study of safety and efficacy
Padia, S. A., Johnson, G. E., Agopian, V. G., DiNorcia, J., Srinivasa, R. N., Sayre, J. W., & Shin, D. S. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26223 · Cited by 41
Role of Thermal Ablation in Colorectal Cancer Lung Metastases
Delpla, A., de Baère, T., Varin, E., Deschamps, F., Roux, C., & Tselikas, L. (2021) · Cancers · doi:10.3390/cancers13040908 · Cited by 41
Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity
Palko-Łabuz, A., Maksymowicz, J., Sobieszczańska, B., Wikiera, A., Skonieczna, M., Wesołowska, O., & Środa-Pomianek, K. (2021) · Cancers · doi:10.3390/cancers13122952 · Cited by 41
Mutant RAS and the tumor microenvironment as dual therapeutic targets for advanced colorectal cancer
Janssen, J. B. E., Medema, J. P., Gootjes, E. C., Tauriello, D. V. F., & Verheul, H. M. W. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102433 · Cited by 42
YAP/TAZ signalling in colorectal cancer: lessons from consensus molecular subtypes
Mouillet-Richard, S., & Laurent-Puig, P. (2020) · Cancers · doi:10.3390/cancers12113160 · Cited by 40
Self-citation
The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
You, W., Sheng, N., Yan, L., Chen, H., Gong, J., Zheng-hui, H., Zheng, K., Chen, Z., Yf, W., Tan, G., et al. (2019) · Journal of Cancer · doi:10.7150/jca.31660 · Cited by 40
Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases
Kurilova, I., Beets‐Tan, R. G. H., Flynn, J. R., Gönen, M., Ulaner, G. A., Petre, E. N., Boas, F. E., Ziv, E., Yarmohammadi, H., Klompenhouwer, E. G., et al. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.08.004 · Cited by 40
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer
Lyskjær, I., Kronborg, C. J. S., Rasmussen, M. H., Sørensen, B. S., Demuth, C., Rosenkilde, M., Frydendahl, A., Knudsen, M., Vang, S., Krag, S. R. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47708-1 · Cited by 43
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
Turano, M., Delrio, P., Rega, D., Cammarota, F., Polverino, A., Duraturo, F., Izzo, P., & Rosa, M. D. (2019) · Cancers · doi:10.3390/cancers11121932 · Cited by 40
Anticancer potential of an exopolysaccharide from Lactobacillus helveticus MB2-1 on human colon cancer HT-29 cells via apoptosis induction
Xiao, L., Ge, X., Yang, L., Chen, X., Xu, Q., Rui, X., Fan, X., Li, F., Zhang, Q., Dong, M., et al. (2020) · Food & Function · doi:10.1039/d0fo01345e · Cited by 40
The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care
Derksen, J. W. G., Vink, G. R., Elferink, M. A. G., Roodhart, J. M. L., Verkooijen, H. M., van Grevenstein, W. M. U., Siersema, P. D., May, A. M., Koopman, M., The PLCRC Study Group, et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79890-y · Cited by 40
Self-citation
The new insight of treatment in Cholangiocarcinoma
Li, Y., Song, Y., & Liu, S. (2022) · Journal of Cancer · doi:10.7150/jca.68264 · Cited by 40
Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
Mo, X., Huang, X., Feng, Y., Wei, C., Liu, H., Ru, H., Qin, H., Lai, H., Wu, G., Xie, W., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1832347 · Cited by 38
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial
Adams, R. A., Fisher, D. J., Graham, J., Seligmann, J. F., Seymour, M., Kaplan, R. S., Yates, E., Parmar, M., Richman, S. D., Quirke, P., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01436 · Cited by 39
Self-citation
Liver transplantation in metastatic colorectal cancer: are we ready for it?
Ros, J., Salvà, F., Dopazo, C., López-Valbuena, D., Gonzalez, N. S., Baraibar, I., Charco, R., Tabernero, J. M., & Élez, E. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02213-1 · Cited by 40
Self-citation
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
Ciracì, P., Studiale, V., Taravella, A., Antoniotti, C., & Cremolini, C. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00965-0 · Cited by 47
Current and future biomarkers in the treatment of colorectal cancer
Cuyle, P.-J. A., & Prenen, H. (2016) · Acta Clinica Belgica · doi:10.1080/17843286.2016.1262996 · Cited by 40
Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review
Gouverneur, A., Salvo, F., Berdaï, D., Moore, N. D., Fourrier‐Réglat, A., & Noïze, P. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.08.001 · Cited by 41
Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience
Johnson, B., Jin, Z., Truty, M. J., Smoot, R. L., Nagorney, D. M., Kendrick, M. L., Kipp, B. R., & Grothey, A. F. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0230 · Cited by 41
Self-citation
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
Yao, J., Zang, W., Ge, Y., Weygant, N., Yu, P., Li, L., Rao, G., Jiang, Z., Yan, R., He, L., et al. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4248971 · Cited by 40
Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial
Sobhani, I., Itti, E., Luciani, A., Baumgaertner, I., Layese, R., André, T., Ducreux, M. P., Gornet, J., Goujon, G., Aparicio, T., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy031 · Cited by 39
Self-citation
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials
Peeters, M., Price, T. J., Taı̈eb, J., Geißler, M., Rivera, F., Canon, J.-L. R., Pentheroudakis, G. E., Koukakis, R., Burdon, P., & Siena, S. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0165-z · Cited by 39
Self-citation
Bridge-to-surgery versus emergency surgery in the management of left-sided acute malignant colorectal obstruction — Efficacy, safety and long-term outcomes
Rodrigues‐Pinto, E., Morais, R., Coelho, C., Pereira, P., Repici, A., & Macedo, G. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.11.006 · Cited by 39
Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study
Peeters, M., Price, T. J., Boedigheimer, M. J., Kim, T. W., Ruff, P., Gibbs, P., Thomas, A., Demonty, G., Hool, K., & Ang, A. L. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2072 · Cited by 39
Self-citation
The identification of a common different gene expression signature in patients with colorectal cancer
Zhao, Z., Fan, X., Yang, L., Song, J., Fang, S., Tu, J., Chen, M., Zheng, L., Wu, F., Zhang, D., et al. (2019) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2019145 · Cited by 39
Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
Ichida, H., Mise, Y., Ito, H., Ishizawa, T., Inoue, Y., Takahashi, Y., Shinozaki, E., Yamaguchi, K., & Saiura, A. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1641-5 · Cited by 40
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
Guarini, C., Grassi, T., Pezzicoli, G., & Porta, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136813 · Cited by 41
Targeting KRASG12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
Ji, J., Wang, C., & Fakih, M. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s340392 · Cited by 39
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
Fernández Montes, A., Martínez Lago, N., Covela Rúa, M., de la Cámara Gómez, J., González Villaroel, P., Méndez Méndez, J. C., Jorge Fernández, M., Salgado Fernández, M., Reboredo López, M., Quintero Aldana, G., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.1903 · Cited by 38
The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer
Su, C., Olsen, K. A., Bond, C., & Whitehall, V. (2023) · Cancers · doi:10.3390/cancers15030805 · Cited by 37
Immunotherapy for gastric cancers: emerging role and future perspectives
Bonotto, M., Garattini, S. K., Basile, D., Ongaro, E., Fanotto, V., Cattaneo, M., Cortiula, F., Iacono, D., Cardellino, G. G., Pella, N., et al. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1313113 · Cited by 38
Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization
Rangraz, E. J., Coudyzer, W., Maleux, G. A., Baete, K., Deroose, C. M., & Nuyts, J. L. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0485-x · Cited by 37
Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment
Marı́n, J. J. G., Macı́as, R. I. R., Monte, M. J., Herráez, E., Peleteiro‐Vigil, A., de Blas, B. S., Sanchon-Sanchez, P., Temprano, Á. G., Espinosa-Escudero, R. A., Lozano, E., et al. (2020) · Cancers · doi:10.3390/cancers12092605 · Cited by 39
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)
Sefrioui, D., Beaussire, L., Gillibert, A., Blanchard, F., Touré, E., Bazille, C., Perdrix, A., Ziegler, F., Gangloff, A., Hassine, M., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01431-9 · Cited by 38
Stereotactic Thermal Ablation of Liver Tumors: 3D Planning, Multiple Needle Approach, and Intraprocedural Image Fusion Are the Key to Success—A Narrative Review
Laimer, G., Schullian, P., & Bale, R. J. (2021) · Biology · doi:10.3390/biology10070644 · Cited by 38
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories
Tack, V., Schuuring, E. M. D., Keppens, C., Hart, N. A. ‘., Pauwels, P., van Krieken, J. H., & Dequeker, E. M. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0204-9 · Cited by 36
Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis
Tian, Y., Wang, Y., Wen, N., Wang, S., Li, B., & Liu, G. (2024) · BMC Cancer · doi:10.1186/s12885-024-12162-4 · Cited by 37
Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial
Adam, R. A., Badrudin, D., Chiche, L., Bucur, P. O., Scatton, O., Granger, V., Ducreux, M. P., Cillo, U., Cauchy, F., Lesurtel, M., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102608 · Cited by 37
Self-citation
Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab—20 Years of Therapeutic Success and Controversy
Chitoran, E., Rotaru, V., Stefan, D. C., Gullo, G., & Simion, L. (2025) · Cancers · doi:10.3390/cancers17071126 · Cited by 42
High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection
Lu, Z., Peng, J., Wang, Z., Pan, Z., Yuan, Y., Wan, D., & Li, B. (2016) · Medical Oncology · doi:10.1007/s12032-016-0838-5 · Cited by 37
Clinical Impact of Preoperative Chemotherapy on Microscopic Cancer Spread Surrounding Colorectal Liver Metastases
Nishioka, Y., Shindoh, J., Yoshioka, R., Gonoi, W., Abé, H., Okura, N., Yoshida, S., Sakamoto, Y., Hasegawa, K., Fukayama, M., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5845-z · Cited by 37
Prognostic value of CD 133+ CD 54+ CD 44+ circulating tumor cells in colorectal cancer with liver metastasis
Fang, C., Fan, C., Wang, C., Huang, Q., Meng, W., Yu, Y., Yang, L., Hu, J., Li, Y., Mo, X., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1241 · Cited by 39
Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group
Keikes, L., van Oijen, M. G. H., Lemmens, V. E. P. P., Koopman, M., & Punt, C. J. A. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.10.007 · Cited by 37
Self-citation
Survival Benefit of Palliative Local Treatments and Efficacy of Different Pharmacotherapies in Colorectal Cancer With Lung Metastasis: Results From a Large Retrospective Study
Wang, Z., Wang, X., Yuan, J., Zhang, X., Zhou, J., Lu, M. S., Liu, D., Li, J., & Shen, L. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.12.005 · Cited by 37
Management and Grading of EGFR Inhibitor-Induced Cutaneous Toxicity
Beech, J., Germetaki, T., Judge, M. R., Paton, N., Collins, J., Garbutt, A., Braun, M., Fenwick, J., & Saunders, M. P. (2018) · Future Oncology · doi:10.2217/fon-2018-0187 · Cited by 37
The role of interventional oncology in the treatment of colorectal cancer liver metastases.
Tsitskari, M., Filippiadis, D. K., Kostantos, C., Palialexis, K., Zavridis, P., Kelekis, N., & Brountzos, Ε. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2018.0338 · Cited by 37
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis
Galvano, A., Taverna, S., Badalamenti, G., Incorvaia, L., Castiglia, M., Barraco, N., Passiglia, F., Fulfaro, F., Beretta, G. D., Duro, G., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919874653 · Cited by 36
Treatment of colorectal cancer in Sub‐Saharan Africa: Results from a prospective Nigerian hospital registry
Sharma, A. S., Alatise, O. I., Adisa, A., Arowolo, O. A., Olasehinde, O. O., Famurewa, O. C., Omisore, A. D., Komolafe, A. O., Olaofe, O. O., Katung, A., et al. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25768 · Cited by 37
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
Yao, F., An, Y., Li, X., Li, Z., Duan, J., & Yang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s240083 · Cited by 37
Radiogenomics in Colorectal Cancer
Badic, B., Tixier, F., Rest, C. C. L., Hatt, M., & Visvikis, D. (2021) · Cancers · doi:10.3390/cancers13050973 · Cited by 40
Detection and Clinical Value of Circulating Tumor Cells as an Assisted Prognostic Marker in Colorectal Cancer Patients
Pan, R.-J., Hong, H., Sun, J. P., Yu, C., Liu, H.-S., Li, P.-Y., & Zheng, M.-H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s300554 · Cited by 37
Development and validation of a gene signature classifier for consensus molecular subtyping of colorectal carcinoma in a CLIA-certified setting
Morris, J. S., Luthra, R., Liu, Y., Duose, D. Y., Lee, W., Reddy, N. G., Windham, J., Chen, H., Tong, Z., Zhang, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2403 · Cited by 36
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
Osterlund, P. J., Kinos, S., Pfeiffer, P., Salminen, T., Kwakman, J. J. M., Frödin, J.-E., Shah, C.-H., Sørbye, H., Ristamäki, R., Halonen, P., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100427 · Cited by 36
Self-citation
Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study
Martinelli, E., Cremolini, C., Mazard, T., Vidal, J., Virchow, I., Tougeron, D., Cuyle, P., Chibaudel, B., Kim, S. C. H., Ghanem, I., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100603 · Cited by 38
Self-citation
The management of colorectal liver metastases
Maher, B., Ryan, E., Little, M. W., Boardman, P., & Stedman, B. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.05.016 · Cited by 35
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma
Sönnichsen, R., Hennig, L., Blaschke, V., Winter, K., Körfer, J., Haehnel, S., Monecke, A., Wittekind, C., Jansen‐Winkeln, B., Thieme, R., et al. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.11.002 · Cited by 38
Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications
Norčič, G. (2018) · Micromachines · doi:10.3390/mi9060300 · Cited by 37
Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway
Wen, S., Chen, Y., Deng, C., Zhang, C.-Q., & Jiang, M. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.033 · Cited by 36
Performance of prediction models on survival outcomes of colorectal cancer with surgical resection: A systematic review and meta-analysis
He, Y., Ong, A. Y., Li, X., Din, F. V., Brown, E. R., Timofeeva, M. N., Wang, Z., Farrington, S. M., Campbell, H., Dunlop, M. G., et al. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.05.014 · Cited by 35
Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
Haele, M. V., Borght, S. V., Ceulemans, A., Wieërs, M. L. A. J., Metsu, S., Sagaert, X., & Weynand, B. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205970 · Cited by 36
A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer
Ou, B., Cheng, X., Xu, Z., Chen, C., Shen, X., Zhao, J., & Lu, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1906-5 · Cited by 36
Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer
Picardo, F., Romanelli, A., Muinelo‐Romay, L., Mazza, T., Fusilli, C., Parrella, P., Barbazán, J., López‐López, R., Barbano, R., Robertis, M. D., et al. (2019) · Cancers · doi:10.3390/cancers11101598 · Cited by 36
Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
Nunes, L., Aasebø, K., Mathot, L., Ljungström, V., Edqvist, P.-H. D., Sundström, M., Dragomir, A., Pfeiffer, P., Ameur, A., Pontén, F., et al. (2020) · Acta Oncologica · doi:10.1080/0284186x.2019.1711169 · Cited by 36
Self-citation
Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision
Reberšek, M. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0031 · Cited by 36
Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST)
Tsai, H., Huang, C., Lin, Y.-W., Wang, J., Wu, C., Sung, Y., Chen, T.-L., Wang, H., Tang, H.-C., Chen, J.-B., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.031 · Cited by 34
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib ± binimetinib or alpelisib
Huijberts, S. C. F. A., Boelens, M. C., Bernards, R., & Opdam, F. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01147-2 · Cited by 36
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives
Martínez, M. C. R., Modrego, A., Espinosa-Olarte, P., Salvia, A. L., & García‐Carbonero, R. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01008-5 · Cited by 36
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
Napolitano, S., Martini, G., Ciardiello, D., Di Maio, M., Normanno, N., Avallone, A., Martinelli, E., Maiello, E., Troiani, T., & Ciardiello, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.940523 · Cited by 35
Self-citation
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer
Beekhof, R., Bertotti, A., Böttger, F., Vurchio, V., Cottino, F., Zanella, E. R., Migliardi, G., Viviani, M., Grassi, E., Lupo, B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abm3687 · Cited by 37
Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus
Leonhardt, C.-S., Stamm, T., Hank, T. P., Prager, G. W., & Strobel, O. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.102067 · Cited by 35
Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients
Ciepiela, I., Szczepaniak, M., Ciepiela, P., Hińcza, K., Kopczyński, J., Macek, P., Kubicka, K., Chrapek, M., Tyka, M., Góźdź, S. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55139-w · Cited by 42
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial
Ruff, P., Cutsem, E. V., Lakomý, R., Prausová, J., Hazel, G. A. V., Moiseyenko, V. M., Soussan-Lazard, K., Dochy, E., Magherini, E., Macarulla, T. M., et al. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.07.010 · Cited by 36
Self-citation

Authors: Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W. J. G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T. J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H. J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., & Arnold, D.
Affiliations: Universitat de València (ES)
Hôpital Paul-Brousse (FR)
Ospedale Policlinico San Martino (IT)
Tel Aviv University (IL)
University of Turin (IT)
Northwestern Medicine (US)
Unified Szent István and Szent László Hospital (HU)
University of Campania "Luigi Vanvitelli" (IT)
Institut de Cancérologie de l'Ouest (FR)
Université Paris-Saclay (FR)
University of Pisa (IT)
Mayo Clinic (US)
Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
KU Leuven (BE)
Ludwig-Maximilians-Universität München (DE)
Universidade de São Paulo (BR)
Klinikum Oldenburg (DE)
Ospedale Papa Giovanni XXIII (IT)
Chinese University of Hong Kong (HK)
University of Oxford (GB)
Aichi Cancer Center (JP)
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
Institute of Cancer Research (GB)
Bank of Cyprus Oncology Center (CY)
University of Ioannina (GR)
Odense University Hospital (DK)
Queen Elizabeth Hospital (AU)
Amsterdam UMC Location University of Amsterdam (NL)
University Hospital Magdeburg (DE)
University Hospital of Geneva (CH)
Institut Català d'Oncologia (ES)
Comprehensive Cancer Center Vienna (AT)
Martin Luther University Halle-Wittenberg (DE)
Vall d'Hebron Hospital Universitari (ES)
Universitair Ziekenhuis Leuven (BE)
Imperial College Healthcare NHS Trust (GB)
National Cancer Center Hospital East (JP)
Hôpital Européen Georges-Pompidou (FR)
ORCID: Cervantes, A.
Adam, R.
Sobrero, A.
Bardelli, A.
Benson, A.
Bodoky, G.
Ciardiello, F.
Douillard, J.-Y.
Ducreux, M.
Falcone, A.
Grothey, A.
Gruenberger, T.
Haustermans, K.
Heinemann, V.
Hoff, P.
Labianca, R.
Ma, B.
Maughan, T.
Muro, K.
Normanno, N.
Oyen, W.J.G.
Papamichael, D.
Pentheroudakis, G.
Pfeiffer, P.
Price, T.J.
Punt, C.
Ricke, J.
Salazar, R.
Schmoll, H.J.
Tabernero, J.
Tejpar, S.
Wasan, H.
Yoshino, T.
Zaanan, A.
Arnold, D.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2016-08
Volume: 27
Issue: 8
Pages: 1386-1422
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1093/annonc/mdw235
OpenAlex: W2470575266
Cited by: 3,421
References: 309
Citations by year: 2026: 199 · 2025: 236 · 2024: 297 · 2023: 364 · 2022: 481 · 2021: 518 · 2020: 444 · 2019: 365 · 2018: 279 · 2017: 189 · 2016: 39
FWCI: 155.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1191 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Lirias (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Cancer Research UK (13363)
National Institute for Health and Care Research (11/100/50)
Topics: Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
Keywords: metastatic colorectal cancer, colorectal cancer, surgical resection of metastases, systemic therapy, multidisciplinary management, treatment decision-making, evidence-based recommendations
MeSH terms: Humans, Neoplasm Metastasis, Prognosis, Biomarkers, Tumor, Colorectal Neoplasms, Guidelines as Topic, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks